These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37408777)

  • 1. Implications of inflammatory cell death-related IFNG and co-expressed RNAs (AC006369.1 and CCR7) in breast carcinoma prognosis, and anti-tumor immunity.
    Deng Y; Li Z; Pan M; Wu H; Ni B; Han X
    Front Genet; 2023; 14():1112251. PubMed ID: 37408777
    [No Abstract]   [Full Text] [Related]  

  • 2. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation.
    Li L; Yang W; Jia D; Zheng S; Gao Y; Wang G
    Breast Cancer; 2023 Jul; 30(4):666-684. PubMed ID: 37178414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel PD-1/PD-L1 pathway molecular typing-related signature for predicting prognosis and the tumor microenvironment in breast cancer.
    Man Y; Dai C; Guo Q; Jiang L; Shi Y
    Discov Oncol; 2023 May; 14(1):59. PubMed ID: 37154982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy.
    Ji H; Ba Y; Ma S; Hou K; Mi S; Gao X; Jin J; Gong Q; Liu T; Wang F; Liu Z; Li S; Du J; Hu S
    Front Immunol; 2021; 12():729359. PubMed ID: 34566988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Immune-Related Long Noncoding RNA Pair as a New Biomarker to Predict the Prognosis of Patients in Breast Cancer.
    Jiang H; Sun J; Liu F; Wu X; Wen Z
    Front Genet; 2022; 13():895200. PubMed ID: 35812755
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.
    Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q
    Front Genet; 2022; 13():1053263. PubMed ID: 36712869
    [No Abstract]   [Full Text] [Related]  

  • 8. Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer.
    Yu Z; Zhu Y; Ji J
    Medicine (Baltimore); 2023 Jul; 102(28):e34287. PubMed ID: 37443486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IFN-γ-related long non-coding RNA signature predicts prognosis and indicates immune microenvironment infiltration in uterine corpus endometrial carcinoma.
    Gu C; Lin C; Zhu Z; Hu L; Wang F; Wang X; Ruan J; Zhao X; Huang S
    Front Oncol; 2022; 12():955979. PubMed ID: 35957871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Holliday Cross-Recognition Protein
    Luo D; Liao S; Liu Y; Lin Y; Li Y; Liao X
    Pathol Oncol Res; 2022; 28():1610506. PubMed ID: 35783358
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer.
    Wu Q; Zheng S; Lin N; Xie X
    BMC Med Genomics; 2023 Apr; 16(1):87. PubMed ID: 37098532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy-related IFNG is a prognostic and immunochemotherapeutic biomarker of COAD patients.
    Yue T; Cai Y; Zhu J; Liu Y; Chen S; Wang P; Rong L
    Front Immunol; 2023; 14():1064704. PubMed ID: 36756126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.
    Liu J; Wei Y; Wu Y; Li J; Sun J; Ren G; Li H
    Front Immunol; 2021; 12():657950. PubMed ID: 33936088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 2-Gene Signature Related to Interferon-Gamma Predicts Prognosis and Responsiveness to Immune Checkpoint Blockade of Glioma.
    Li Y; Ji H; Gao X
    Front Med (Lausanne); 2022; 9():846847. PubMed ID: 35492352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.
    Song C; Shang F; Tu W; Liu X
    BMC Cancer; 2023 Mar; 23(1):296. PubMed ID: 37004015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Expression Level of PD1 by Tumor-Infiltrating CD8
    Kim HD; Song GW; Park S; Jung MK; Kim MH; Kang HJ; Yoo C; Yi K; Kim KH; Eo S; Moon DB; Hong SM; Ju YS; Shin EC; Hwang S; Park SH
    Gastroenterology; 2018 Dec; 155(6):1936-1950.e17. PubMed ID: 30145359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
    Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
    Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients.
    Karachaliou N; Gonzalez-Cao M; Crespo G; Drozdowskyj A; Aldeguer E; Gimenez-Capitan A; Teixido C; Molina-Vila MA; Viteri S; De Los Llanos Gil M; Algarra SM; Perez-Ruiz E; Marquez-Rodas I; Rodriguez-Abreu D; Blanco R; Puertolas T; Royo MA; Rosell R
    Ther Adv Med Oncol; 2018; 10():1758834017749748. PubMed ID: 29383037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An autophagy-related long non-coding RNA prognostic model and related immune research for female breast cancer.
    Chen J; Li X; Yan S; Li J; Zhou Y; Wu M; Ding J; Yang J; Yuan Y; Zhu Y; Wu W
    Front Oncol; 2022; 12():929240. PubMed ID: 36591508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.